Provenienza dei contatti di primo grado di Felix Kim
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Felix Kim tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| MEDIABAY INC | Internet Retail | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Compliance Officer | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Compliance Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Brown University | College/University | Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member | |
| HUNTSWORTH PLC | Miscellaneous Commercial Services | Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Masters Business Admin | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
The DuPont Safety & Protection
 The DuPont Safety & Protection TextilesProcess Industries The DuPont Safety & Protection produces protective fabrics and accessories. The firm offers composite technology, HMT, needle punch, spun laced, spun bonded products. it serves to the carpeting, construction, electronics, aerospace, automotive printing and food industry. The company is headquartered in Wilmington, DE. | Textiles | Corporate Officer/Principal | |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | General Counsel Director/Board Member | |
| Bryn Mawr Hospital Foundation | Director/Board Member | ||
| Prostate Cancer Foundation | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
The Friends of the Woodlawn Library, Inc.
 The Friends of the Woodlawn Library, Inc. Miscellaneous Commercial ServicesCommercial Services The Friends of the Woodlawn Library, Inc. engages in managing library. The company is headquartered in Wilmington, DE. | Miscellaneous Commercial Services | Treasurer | |
OUP Management Co. LLC
 OUP Management Co. LLC Investment ManagersFinance OUP Management Co. LLC (Osage Partners) is a venture capital firm founded by Robert Adelson and Louis Berneman in 1990. The firm is headquartered in Bala Cynwyd, Pennsylvania. | Investment Managers | Private Equity Analyst | |
YMCA of Delaware
 YMCA of Delaware Miscellaneous Commercial ServicesCommercial Services YMCA of Delaware is a non-profit organization that offers services related to youth development, healthy living, and social responsibility. The non-profit company is based in Wilmington, DE. | Miscellaneous Commercial Services | Chairman | |
DuPont Personal Protection
 DuPont Personal Protection Wholesale DistributorsDistribution Services DuPont Personal Protection supplies personal protective equipment which includes body armor, chemical protective garments and apparels. The company is headquartered in Mississauga, Canada. | Wholesale Distributors | Corporate Officer/Principal | |
| TREVENA, INC. | Pharmaceuticals: Major | Compliance Officer Comptroller/Controller/Auditor | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| The Boys & Girls Clubs of Philadelphia | Director/Board Member | ||
| The Haverford School | Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| DuPont Apparel & Textile Sciences | Director of Finance/CFO | ||
| Du Pont Imaging Technologies, Inc. | Corporate Officer/Principal | ||
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bristol-Myers Squibb SA (Switzerland) | General Counsel | ||
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
| Stanford Law School | College/University | Graduate Degree | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Investment Managers | Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director of Finance/CFO | |
PureSight Advisory LLC
 PureSight Advisory LLC Packaged SoftwareTechnology Services PureSight Advisory LLC provides management software solutions. The private company is based in Newark. | Packaged Software | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director of Finance/CFO | |
| The Biobreak Organization, Inc. | Director/Board Member | ||
| Drug & Device Development Solutions LLC | President | ||
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Medical/Nursing Services | Director/Board Member | |
| CINGULATE INC. | Pharmaceuticals: Major | Director/Board Member | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 42 |
| Canada | 3 |
| Svizzera | 3 |
| Irlanda | 2 |
| Danimarca | 2 |
Settori
| Health Technology | 18 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Process Industries | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 83 |
| Corporate Officer/Principal | 49 |
| Independent Dir/Board Member | 38 |
| Chairman | 20 |
| Undergraduate Degree | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Richard Berman | 61 |
| Elizabeth Anderson | 24 |
| J. Sorensen | 16 |
| Evan G. Dick | 14 |
| Linda West | 12 |
| Jennifer Stacey | 12 |
| Philip Kantoff | 11 |
| Scott Applebaum | 11 |
| Martin Lehr | 8 |
| Richard Morris | 7 |
| Alex Levit | 7 |
| Tarek Sahmoud | 6 |
| Jennifer Minai-Azary | 6 |
| Christopher Beck | 6 |
| Mark Fletcher | 5 |
- Borsa valori
- Insiders
- Felix Kim
- Connessioni Società
